Corcept Therapeutics
CORT
#2468
Rank
$5.88 B
Marketcap
$56.20
Share price
0.21%
Change (1 day)
116.67%
Change (1 year)

Corcept Therapeutics (CORT) - Cash on Hand

Cash on Hand as of September 2024 : $0.38 Billion USD

According to Corcept Therapeutics 's latest financial reports the company has $0.38 Billion USD in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Corcept Therapeutics - Cash on Hand chart (from 2003 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31$0.36 B-14.7%
2022-12-31$0.43 B93.11%
2021-12-31$0.22 B-49.28%
2020-12-31$0.44 B59.69%
2019-12-31$0.27 B33.47%
2018-12-31$0.20 B132.98%
2017-12-31$88.74 M72.2%
2016-12-31$51.53 M27.45%
2015-12-31$40.43 M66.76%
2014-12-31$24.24 M-55.81%
2013-12-31$54.87 M-41.01%
2012-12-31$93.03 M134.72%
2011-12-31$39.63 M61.26%
2010-12-31$24.57 M2.98%
2009-12-31$23.86 M30.36%
2008-12-31$18.3 M5.43%
2007-12-31$17.36 M83.65%
2006-12-31$9.45 M-67.48%
2005-12-31$29.08 M-22.25%
2004-12-31$37.4 M223.06%
2003-12-31$11.57 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
$20.29 B 5,236.60%๐Ÿ‡บ๐Ÿ‡ธ USA
$8.09 B 2,028.12%๐Ÿ‡บ๐Ÿ‡ธ USA
$14.02 B 3,586.21%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
$3.51 B 825.08%๐Ÿ‡บ๐Ÿ‡ธ USA
$9.95 B 2,516.63%๐Ÿ‡บ๐Ÿ‡ธ USA
$14.59 B 3,736.87%๐Ÿ‡บ๐Ÿ‡ธ USA
$0.18 B-50.23%๐Ÿ‡บ๐Ÿ‡ธ USA
$0.24 B-34.86%๐Ÿ‡บ๐Ÿ‡ธ USA
$0.93 B 144.64%๐Ÿ‡บ๐Ÿ‡ธ USA